Medicine
Global Polio Eradication Challenges in Conflict-Affected Regions
Quick fact
In 1988, polio was endemic in 125 countries; by 2021, only two countries—Afghanistan and Pakistan—never interrupted transmission, both wracked by conflict. Even when a country eliminates the virus, it can be re-imported from a conflict-ridden neighbor.
Why this is interesting
Polio is on the verge of extinction—but it clings to life in the world's most dangerous places. Why can't we finish the job?
Read the full explanation
Understanding Global Polio Eradication Challenges in Conflict-Affected Regions
Imagine a vaccination campaign as a fire brigade trying to put out a wildfire. In most areas, they reach every house, extinguishing the embers. But in conflict-affected regions, the brigade cannot access certain neighborhoods because of ongoing fighting. Some houses remain unvaccinated. Poliovirus, a highly infectious agent transmitted through contaminated water or food, finds these unprotected children and spreads. The disease can cause irreversible paralysis, and even if a child shows no symptoms, they can silently carry the virus and infect others. The Global Polio Eradication Initiative (GPEI) relies on repeatedly vaccinating every child under five with the oral polio vaccine (OPV) to build community-wide immunity. When vaccination coverage is high, the virus cannot find new hosts and dies out. But in conflict zones, insecurity prevents health workers from reaching many communities. Vaccination campaigns are postponed or interrupted, leaving pockets of unvaccinated children. These pockets become reservoirs for the virus, allowing it to persist locally and even jump to neighboring regions or across borders.
A deeper explanation
The core challenge lies in the mechanics of polio transmission and the nature of conflict. Polio spreads through fecal-oral routes, meaning it thrives in areas with poor sanitation and weak health systems—common in conflict-affected regions. The polio vaccine (OPV) contains a weakened live virus that replicates in the gut, providing excellent immunity, but requires multiple doses and high coverage (over 80-90%) to interrupt transmission. Conflict disrupts every pillar of eradication: it blocks access for vaccination teams, displaces families who miss routine doses, destroys health infrastructure, and creates population movements that carry the virus across borders. Even more insidious is the role of vaccine-derived poliovirus (VDPV). In communities with very low vaccination coverage, the weakened virus in OPV can spread from child to child for a long time. As it replicates, it can mutate genetically and regain the ability to cause paralysis. This creates new outbreaks in areas already struggling with conflict, such as in Syria and parts of Africa. Thus, conflict-affected regions become a double threat: they harbor wild poliovirus and also spawn VDPV. The solution requires not just vaccines, but negotiation and trust. Health workers have negotiated temporary ceasefires—'days of tranquility'—to reach children, and use community-based approaches. However, mistrust and insecurity remain formidable barriers, making the final push for eradication a geopolitical and humanitarian challenge as much as a medical one.